4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001682019-25-000003
Chief Executive Officer sold 13,081 shares at $58.15 ($760,660)
- Chief Executive Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…